Literature DB >> 2735457

Intraventricular CCK inhibits food intake and gastric emptying in baboons.

D P Figlewicz1, A J Sipols, D Porte, S C Woods, R A Liddle.   

Abstract

To evaluate the role of cholecystokinin (CCK) as a physiological regulator of meal size and gastric emptying in the baboon, we measured plasma CCK bioactivity during 30-min meals alone and after intravenous or intraventricular infusions of CCK COOH-terminal octapeptide (CCK-8). Both intravenous (2 micrograms/kg) and intraventricular (1 microgram/kg) CCK-8 administration resulted in plasma CCK elevations comparable with normal prandial CCK levels: peak plasma levels were 4.1 +/- 0.9, 7.1 +/- 1.1, and 4.9 +/- 2.2 pM for pooled intravenous and intraventricular control, intravenous, and intraventricular conditions. Also, both treatments appeared to reduce gastric emptying as indicated by a significant suppression of postprandial plasma insulin and glucose levels. However, only intraventricular CCK reliably reduced meal size (percent of control meal size was 91 +/- 5% or 43 +/- 19% with intravenous or intraventricular CCK). We conclude that circulating endogenous CCK is a potent postprandial endocrine regulator of gastric emptying. However, the ability of CCK to decrease meal size may require direct interaction with the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2735457     DOI: 10.1152/ajpregu.1989.256.6.R1313

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  5 in total

Review 1.  The behavioral pharmacology of anorexigenic drugs in nonhuman primates: 30 years of progress.

Authors:  Richard W Foltin
Journal:  Behav Pharmacol       Date:  2012-09       Impact factor: 2.293

Review 2.  Hyperphagia and obesity in OLETF rats lacking CCK-1 receptors.

Authors:  Timothy H Moran; Sheng Bi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

3.  The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans.

Authors:  D Matzinger; L Degen; J Drewe; J Meuli; R Duebendorfer; N Ruckstuhl; M D'Amato; L Rovati; C Beglinger
Journal:  Gut       Date:  2000-05       Impact factor: 23.059

4.  Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide.

Authors:  R J Lieverse; J B Jansen; A A Masclee; L C Rovati; C B Lamers
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

5.  Meal-anticipatory glucagon-like peptide-1 secretion in rats.

Authors:  Torsten P Vahl; Deborah L Drazen; Randy J Seeley; David A D'Alessio; Stephen C Woods
Journal:  Endocrinology       Date:  2009-11-13       Impact factor: 4.736

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.